| Date | Title | Description |
| 27.02.2026 | SHINE Technologies Secures $240M, Propelling Fusion and Medical Isotopes Forward | SHINE Technologies secured $240 million in new equity funding, pushing its total capital raised beyond $1 billion. Dr. Patrick Soon-Shiong, a noted biotech visionary, joined its Board of Directors. This substantial investment will vigorousl... |
| 26.02.2026 | Shine Raises $240M in Funding | Shine Technologies, a Janesville, WI-based nuclear fusion company, raised $240M in equity funding.
The round was led by NantWorks with additional participation from Fidelity Management and Research Company, Sumitomo Corporation of Americas,... |
| 26.02.2026 | SHINE Technologies: $240 Million Raised For Nuclear Fusion And Medical Isotope Expansion | SHINE Technologies, a nuclear fusion company, announced it has raised $240 million in equity funding and appointed Dr. Patrick Soon-Shiong, M.D., Executive Chairman of ImmunityBio and founder of NantWorks, to its Board of Directors. The rou... |
| 07.11.2025 | myLaurel Raises Funding For Advancing Expansion Of Hospital-Level Care In The Home | SteelSky Ventures has led a new investment round in myLaurel, joining Deerfield Management and Google Ventures (GV) to expand myLaurel’s in-home acute care platform across major U.S. health systems. The funding will support nationwide growt... |
| 01.10.2025 | Axon Therapies: $32 Million Series A Secured For Developing Heart Failure Treatments | Axon Therapies, a pioneering company in the medical device field, has announced the closure of an oversubscribed $32 million Series A funding round, focused on developing innovative treatments for heart failure. This funding round was co-le... |
| 26.09.2025 | Axon Therapies Raises $32M in Funding | Co-founder Zoar Engelman, PhD, appointed CEO of Axon Therapies
Axon Therapeutics, a NYC-based clinical-stage medical device company, raised $32M in funding.
The round was led by Earlybird Venture Capital and Santé Ventures, with participati... |
| 27.08.2025 | Reprieve Cardiovascular Raises $61M in Series B Financing | Reprieve Cardiovascular, a Milford, MA-based clinical-stage company pioneering intelligent decongestion management therapy for acute decompensated heart failure (ADHF), raised $61M in Series B funding.
The round was led by Deerfield Managem... |
| 13.08.2025 | Reprieve Cardiovascular Raises $61M to Fund Pivotal Heart Failure Trial | What You Should Know:
– Reprieve Cardiovascular, a clinical-stage company secures $61M in Series B funding led by Deerfield Management and included participation from several other investors, such as Arboretum Ventures, Lightstone Ventures,... |
| 13.08.2025 | Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First Patient in Pivotal Study | — Series B fundraise led by Deerfield Management enables scaling of pivotal clinical trial and commercial readiness activities for Reprieve® System
– First patient enrolled in FASTR II study by Washington University School of Medicine in St... |
| 07.06.2025 | myLaurel: $12 Million Raised For Home-Based Acute And Transitional Care | myLaurel, a healthcare company delivering home-based acute and transitional care, announced it raised additional capital and held an initial closing of $12 million from existing investors. The funding round was led by Deerfield Management a... |
| 15.05.2025 | Cohere Health Secures $90 Million to Revolutionize Clinical Intelligence | In the bustling world of healthcare, where efficiency is king, Cohere Health has emerged as a beacon of innovation. The Boston-based company recently announced a significant milestone: a $90 million Series C funding round. This investment, ... |
| 15.05.2025 | Cohere Health: $90 Million C Round Closed For Clinical Intelligence Solutions | Cohere Health, a leader in clinical intelligence solutions for health plans and risk-bearing providers, announced it has raised $90 million in Series C funding. The funding round was led by Temasek, with continued support from Deerfield Man... |
| 14.05.2025 | Cohere Health Raises $90M Series C Funding | Cohere Health, a Boston, MA-based provider of clinical intelligence solutions for health plans and risk-bearing providers, raised $90M in Series C funding.
The round, which brought the total amount to $200M, was led by Temasek, with partici... |
| 14.05.2025 | Cohere Health Secures $90M to Expand AI-Powered Platform Transforming Health Plan Clinical Decision-Making | What You Should Know:
– Cohere Health®, a leader in clinical intelligence solutions tailored for health plans and risk-bearing providers raises $90M in a Series C funding round led by Temasek, with continued strong support from existing inv... |
| 12.05.2025 | Deerfield Management: Over $600 Million Healthcare Venture Fund Closed | Deerfield Management Company announced the closing of the Deerfield Healthcare Innovations Fund III, a fund of over $600 million that looks to advance healthcare by investing in therapeutics, improving care delivery models, and enhancing em... |
| 08.05.2025 | Atlas: $155 Million Seed Financing And Acquisition Of Assets From Twist Bioscience | Atlas Data Storage – a technology company building end-to-end DNA data storage – announced the closing of a $155 million seed financing and the acquisition of technology assets from Twist Bioscience. The seed funding investors are ARCH Vent... |
| 06.05.2025 | The Future of Data Storage: Atlas Data Storage's Bold Leap into DNA Technology | In the world of technology, innovation is the lifeblood that fuels progress. Atlas Data Storage, a fledgling company based in South San Francisco, has just secured a staggering $155 million in seed funding. This financial boost marks a sign... |
| 06.05.2025 | Deerfield raises $600m for third healthcare VC fund | - |
| 05.05.2025 | Deerfield unveils $600M for emerging healthcare therapeutics and tech | Deerfield Management has unveiled the third installment of its healthcare innovations fund, earmarking more than $600 million for promising therapeutics and technologies.
The funds will also go toward efforts to improve healthcare delivery ... |
| 05.05.2025 | Atlas Data Storage Raises $155M in Seed Funding | Atlas Data Storage, a South San Francisco, CA-based technology company building end-to-end DNA data storage solutions, raised $155m in seed financing.
Backers included ARCH Venture Partners, Deerfield Management, Bezos Expeditions, Tao Capi... |
| 23.04.2025 | Ascertain's $10 Million Boost: A New Dawn for AI in Healthcare | In the bustling world of healthcare, where every second counts, Ascertain has emerged as a beacon of hope. The company recently secured $10 million in Series A funding, led by Deerfield Management, with strategic backing from Northwell Heal... |
| 23.04.2025 | Ascertain Raises $10 Million in Series A Funding to Scale Agentic AI Platform | Reimagining Operational Workflows for Health Systems, Payers, and Independent Provider Groups Led by Deerfield Management, with a strategic investment from Northwell Health, the raise will support Ascertain’s vision for combining humans and... |
| 22.04.2025 | Ascertain Secures $10M to Scale AI-Powered Case Management Solution | What You Should Know:
– Ascertain, a healthcare technology company focused on empowering care teams with artificial intelligence (AI) raises $10M in Series A funding round led by Deerfield Management, featuring strategic participation from ... |
| 05.03.2025 | Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director | ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of... |
| 16.01.2025 | IntusCare Raises $11.5M to Expand Geriatric Care Solutions, Launches CareHub Platform | What You Should Know:
– IntusCare, a provider of predictive analytics solutions for geriatric care, announced it has secured $11.5M in a strategic follow-on financing round led by Deerfield Management, with participation from Citi Impact Fu... |
| 11.01.2025 | Nema Health: Pioneering Virtual Care for PTSD with $14.5 Million Boost | In a world where trauma often lingers like a shadow, Nema Health is stepping into the light. The New Haven-based company has secured $14.5 million in Series A funding, a significant leap toward expanding its innovative virtual treatment for... |
| 11.01.2025 | Nema Health: $14.5 Million (Series A) Raised For Expanding Virtual PTSD Treatment Model | Nema Health, a leading solution for virtual trauma and PTSD care, announced a $14.5 million Series A funding round led by Deerfield Management alongside new participant CVS Health Ventures (CVS Health’s venture capital arm). And Nema’s exis... |
| 14.12.2024 | Pleno: Clinical And Multi-Omics Diagnostics Company Raises $25 Million (Series B) | Pleno, a clinical and multi-omics diagnostics company revolutionizing biological target detection, announced the appointment of Dr. Vik Vaz, M.D., as its new chief executive officer and to serve on its Board of Directors, effective immediat... |
| 13.12.2024 | Pleno's $25M Boost: A New Era in Multi-Omics Diagnostics | In the bustling world of biotechnology, Pleno has just made waves. The San Diego-based company secured $25 million in Series B funding, a significant leap forward in its mission to revolutionize diagnostics. This infusion of capital comes f... |
| 12.12.2024 | Pleno Closes $25M Series B & Appoints Dr. Vik Vaz as CEO | Dr. Vik Vaz, CEO at Pleno
What You Should Know:
– Pleno, an innovative multi-omics diagnostics company, announced it has raised $25M in Series B funding and appointed Dr. Vik Vaz as its new Chief Executive Officer (CEO). Key investors Deerf... |
| 09.11.2024 | Petfolk's $36 Million Leap: A New Era in Veterinary Care | In a world where pets are family, Petfolk is leading the charge in veterinary care. The company recently secured $36 million in Series C funding, a significant boost that promises to reshape the landscape of pet healthcare. This investment,... |
| 08.11.2024 | Petfolk: Veterinary Care Company Raises $36 Million (Series C) | Petfolk, a leading provider of veterinary and urgent care through a network of connected care clinics, announced it has received a $36 million Series C investment led by Deerfield Management. And existing investors Movendo Capital, White St... |
| 14.10.2024 | Dantech Announces Participation as a Silver Sponsor at BioFuture 2024 in New York City | Dantech: Driving Technological Innovation in Health and Life Sciences
Dantech announces Silver Sponsorship at BioFuture NYC, Oct 28-30, showcasing tech that accelerates biology and technology integration
NEW YORK, Oct. 14, 2024 /PRNewswire-... |
| 17.09.2024 | Pairwise: Cultivating the Future of Agriculture with Gene Editing | In the heart of Durham, North Carolina, a revolution is brewing. Pairwise, a technology company at the forefront of gene editing, has just secured $40 million in Series C funding. This latest round, led by Deerfield Management, pushes their... |
| 17.09.2024 | Pairwise raises $40m series C, forms JV with Corteva to accelerate gene editing on row crops | Pairwise, a startup pioneering gene editing in plants, has closed a $40m series C funding round and formed a five-year joint venture collaboration with agtech giant Corteva to advance the tech to increase climate resilience in corn and soy.... |
| 13.09.2024 | SpectraWAVE: $50 Million (Series B) Raised To Advance HyperVue Imaging System | SpectraWAVE., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), announced a $50 million Series B funding round led by Johnson & Johnson Innovation – JJDC and joine... |
| 11.09.2024 | Cure® Announces 2024 XSeed Award Winners, Promoting Women- and Minority-Led Life Science Startups in New York City | Teams led by Carol M. Troy, MD, PhD, of Columbia University Medical Center, and Paraskevi Giannakakou, PhD, of Weill Cornell Medical College, each to receive $250,000 grants
NEW YORK, Sept. 11, 2024 /PRNewswire/ -- Cure, a premier healthcar... |
| 11.09.2024 | SpectraWAVE Raises $50M in Series B Financing | SpectraWAVE, Inc., a Bedford, MA-based medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), raised $50M in Series B funding.
The round was led by Johnson & Johnson Inno... |
| 09.09.2024 | Vesta Healthcare garners $65M for virtual home care platform | Photo: FG Trade/Getty Images
Vesta Healthcare, a virtual care company for individuals receiving home care, closed a $65 million Series C round with new debt financing.
RA Capital Management led the round with participation from Chrysalis Ve... |
| 05.09.2024 | Vesta Healthcare Raises $65M in Financing | Vesta Healthcare, a NYC-based virtual care provider raised $65M in Series C funding with new debt financing.
The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/... |
| 04.09.2024 | Vesta Healthcare: Virtual Care Provider For Those With Home Care Raises $65 Million (Series C) | Vesta Healthcare, a virtual care provider group for people with home care, announced today the closing of $65 million in a Series C round with new debt financing.
This equity round was led by RA Capital Management, with participation from O... |
| 03.09.2024 | Vesta Healthcare Receives 35M Loan Facility From Horizon Technology Finance | Vesta Healthcare (aka Hometeam Technologies, Inc.), a NYC-based tech-enabled clinical services company, receivded a $35M venture loan facility from Horizon Technology Finance (NASDAQ: HRZN).
A $25M portion has been initially funded.
The com... |
| 28.06.2024 | Elion Therapeutics: $81 Million Closed To Transform Treatment Of Life-Threatening Invasive Fungal Infections | Elion Therapeutics, a biotechnology company focused on transforming the treatment of life-threatening invasive fungal infections (IFIs), announced it has closed a $81 million Series B funding round led by Deerfield Management and the AMR Ac... |
| 17.06.2024 | Elion Therapeutics Closes $81M Series B Funding Round | Elion Therapeutics, a NYC-based biotechnology company dedicated to advancing the treatment of life-threatening invasive fungal infections (IFIs), closed a $81M Series B funding.
The round was led by Deerfield Management and the AMR Action F... |
| 17.06.2024 | Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund | - Funds to support the advancement of SF001, a next-generation polyene antifungal designed for reduced toxicity
NEW YORK, June 17, 2024 /PRNewswire/ -- Elion Therapeutics ("Elion", formerly Sfunga Therapeutics), a biotechnology co... |
| 11.06.2024 | Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) | OSAKA, Japan and WALTHAM, Mass., June 11, 2024 /PRNewswire/ -- Ono Pharmaceutical, Co., Ltd. (Chairman and CEO: Gyo Sagara, "Ono") today announced that it has successfully completed the tender offer, previously announced on April ... |
| 05.06.2024 | Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development | Frank Nestle, MD, FMedSci joins Deerfield from previous position as Global Head of Research and Chief Scientific Officer at Sanofi
Nestle will lead therapeutic discovery and development as Partner and Chief Executive Officer of Deerfield Di... |
| 14.05.2024 | Cohere Health Launches Early Trend Signal Intelligence to Predict Utilization Trends Earlier than Claims-based Methods | Leverages intelligent prior authorization to inform policy and financial strategies up to three months earlier
BOSTON, May 14, 2024 /PRNewswire/ -- Cohere Health®, a recognized leader in clinical intelligence and prior authorization automat... |
| 23.04.2024 | Cohere Health and Humana Expand Prior Authorization Partnership, Adding Diagnostic Imaging and Sleep Services | New solutions elevate and expedite patient care with upstream moments of influence
BOSTON and LOUISVILLE, Ky., April 23, 2024 /PRNewswire/ -- Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, an... |
| 22.04.2024 | Value-based care strategy company Lumeris secures $100M | Photo: francescoridolfi.com/Getty Images
Lumeris, a value-based care strategy, technology and operations company, announced it secured $100 million in an equity capital raise led by Deerfield Management.
Endeavor Health joined as a new inve... |
| 23.02.2024 | Reprieve Cardiovascular Revolutionizes Heart Failure Treatment with $42M Funding | Reprieve Cardiovascular, a Milford, MA-based company, secures $42M in Series A funding to advance intelligent fluid management for heart failure patients. Led by Lightstone Ventures and Sante Ventures, the funding will propel Reprieve's mis... |
| 22.02.2024 | Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid Management for Heart Failure | What You Should Know:
– Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
– The Series A round was co-led b... |
| 25.10.2022 | COTA Secures New Financing to Accelerate Cancer Research and Treatment Innovation | What You Should Know:
COTA Expands Services and Approaches Milestone of 2 Million Cancer Lives
Building on this latest round of financing, COTA is also announcing the expansion of its data platform to cover nearly 2 million cancer patient l... |
| 09.08.2022 | The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets | CERRITOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced entry into an agreement for the investment of $11... |
| 19.07.2022 | Humanity Health Raises $6M to Advance Health Equity Through Inclusive Leadership | What You Should Know:
– Humanity Health, a New York City-based career acceleration and talent sourcing platform for underrepresented leaders in healthcare and life sciences, has raised $6 million in Series A funding led by Jumpstart Nova wi... |
| 03.02.2022 | ConcertoCare Raises $105M for Value-Based At-Home Care for Seniors | What You Should Know:
– ConcertoCare, a value-based care provider of at-home care for seniors and other adults with unmet health and social needs raises $105M in Series B funding led by Wells Fargo Strategic Capital. The round also includes... |
| 13.10.2021 | Lark Health Raises $100M for Digital Care Management & Prevention Platform | What You Should Know:
– Lark Health, a healthcare technology company aimed at delivering infinitely scalable, virtual chronic and preventative healthcare through conversational AI announced it has raised $100M in Series D funding led by Dee... |
| 04.08.2021 | Deerfield : Announces New $1.4-billion Private Investment Fund | Deerfield Management Company, a New York City-based healthcare investment firm focused on advancing healthcare through investment, information and philanthropy, today announced that it has launched Deerfield Private Design Fund V, L.P. The ... |
| 29.06.2021 | Blue Cross and Blue Shield Association : NC Invests in Providing Services and Solutions to Independent Physicians, Offering an Alternative Path to Sustainable Practice Growth | 29 Jun 2021 Blue Cross NC Invests in Providing Services and Solutions to Independent Physicians, Offering an Alternative Path to Sustainable Practice Growth
New services to support growth of independent physician practices
DURHAM, N.C. - Br... |
| 28.06.2021 | Novocardia™ Announces $53.7 Million Financing Led by Deerfield Management | |
| 06.04.2021 | 'Unsurprising' but 'deeply disappointing': Deerfield report finds vast gender gap in VC-backed healthcare | Studies on diversity in the life sciences industry often look at the makeup of companies’ employees, executive teams and board members. In a new report, Deerfield Management zeroed in on early-stage companies and the venture capital firms t... |
| 02.03.2021 | Meet the top 8 VC firms that placed the most bets on startups changing how doctors get paid and building the future of medicine | Iyah Romm, Cityblock's CEO, and Toyin Ajayi, the chief health officer. Cityblock Health This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
Healthcare startups trying to change the... |
| 09.02.2021 | Pairwise raises $90m to sell nutrient-dense gene-edited salad leaf | Apples that don’t brown. Lettuce that never wilts. Strawberries that burst with flavor.
Gene editing, it is hoped, could turn all of these appealing notions into realities.
Durham, North Carolina-based Pairwise is aiming to be among the fir... |
| 03.08.2020 | Baird Capital Portfolio Company ReMed Acquires Learning Services | CHICAGO – August 3, 2020 –Baird Capital, the direct private investment arm of Baird, announced today that its portfolio company ReMed had acquired Learning Services Corp. (Learning Services). The two industry leaders in brain injury rehabil... |
| 29.07.2020 | BlackRock Leads Sema4’s $121M Series C | 21 Shares Email Facebook Twitter LinkedIn
Patient-centered health intelligence company Sema4 saw its post-money valuation go above $1 billion after closing an oversubscribed $121 million Series C financing round, the company announced Wedne... |
| 23.06.2020 | Somatus Lands $64M to Expand Value-Based Kidney Care Model | What You Should Know:
– Somatus raises $64M in Series C funding led by Longitudinal Capital to fuel the expansion of its value-based kidney care model.
– Somatus will use the funding to continue to scale its model nationally and invest in t... |
| 24.05.2020 | The Sunday Briefing | #103 | The Vancouver Tech Journal brings you news, insight, opinions, and the lesser-known stories from Vancouver's innovation ecosystem. This is The Sunday Briefing. Enjoy.
My latest piece of writing is a profile of Rich Osborn, the managing part... |
| 22.05.2020 | Nuclear medicine startup ARTMS Products raises $26.4 million CAD Series A | Vancouver-based startup ARTMS Products, which produces medical isotopes, has raised a $26.4 million CAD ($19 million USD) Series A funding round. This round brings the company’s total funding to more than $30 million CAD ($26 million USD).
... |
| 08.04.2020 | Deerfield raises $840m fund targeting cutting-edge drug, medtech development | Deerfield Management Company has hit an $840m final close for its second Healthcare Innovations fund, which will target |
| 07.04.2020 | Deerfield closes $840M Healthcare Venture Fund II to invest in advancements in science for promising therapeutics | Deerfield, a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy, today announced the closing of $840 million in Deerfield Healthcare Innovations Fund ll, which will inves... |
| 07.04.2020 | Deerfield pulls off $840M healthcare venture fund—the 4th in a week | Join the club, Deerfield. The investment management firm raised $840 million for its second healthcare-focused fund, joining Arch Venture Partners, Flagship Pioneering and venBio Partners, all of which announced new funds last week.
The fun... |
| 06.04.2020 | Deerfield Completes Healthcare Venture Fund, at $840M | NYC-based Investment firm Deerfield Management Company, L.P. closed the Deerfield Healthcare Innovations Fund ll, L.P., at $840m.
The Healthcare Innovations Fund II will invest in advancements in science that may lead to important therapeut... |
| 06.04.2020 | Deerfield Closes $840M Healthcare Venture Fund | NEW YORK--(BUSINESS WIRE)--Deerfield Management Company, L.P. today announced the closing of the Deerfield Healthcare Innovations Fund ll, L.P., which will invest in advancements in science that may lead to important therapeutic interventio... |
| 06.04.2020 | Deerfield pulls off $840M healthcare venture fund—the 4th in a week
W h i t e p a p e r
Weighing the Costs: | Join the club, Deerfield. The investment management firm raised $840 million for its second healthcare-focused fund, joining Arch Venture Partners, Flagship Pioneering and venBio Partners, all of which announced new funds last week.
Sponsor... |
| 05.03.2020 | Element Science Nabs $145.6M to Commercialize Wearable Cardioverter Defibrillator | What You Need to Know:
– Element Science raises $145.6M in Series C funding to led by Deerfield Healthcare and Qiming Venture Partners USA, includes Cormorant Asset Management and Invus Opportunities.
– Funding will enable Element Science t... |
| 20.02.2020 | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| 02.01.2020 | Deerfield Management and Duke University Launch Four Points Innovation | Duke University and Deerfield Management Company, a healthcare investment firm, have launched Four Points Innovation, a major translational research collaboration effort.
Spearheaded by Duke University’s Office of Licensing & Ventures (... |
| 14.10.2019 | Top 10 VCs investing in medical device companies | They include NEA, Versant Ventures, SOSV and Innova Memphis
Healthtech is a big and broad space, so much so that there are whole subsectors that see more investments than entire industries.
Medical device companies, for example, raised $2.9... |
| 17.09.2019 | Boulder’s Edgewise Therapeutics closes $50 million Series B financing | Edgewise Therapeutics, a Boulder company working to develop new therapies for treating patients with debilitating musculoskeletal disease, announced the closing of a $50 million Series B financing round on Tuesday.
The funding will help the... |
| 05.10.2018 | Tris Pharma Receives $125M Debt Financing from Deerfield | Deerfield provided $125m to refinance existing debt and provide growth capital to Tris Pharma, Inc., a Monmouth Junction, NJ-based fully integrated pharmaceutical company.
The company intends to use the funds to expand its branded pharmaceu... |
| 26.06.2018 | The Biggest Wisconsin Venture Round of the Decade… Didn’t Happen | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Details surrounding a $127.4 million funding round, which groups that track venture capital investments have said Janesville, WI-based Shine Medical Technologies raised in 201... |
| 25.05.2018 | Pfizer, Merck Lead Strata Oncology’s $26M Series B Round | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
In what company leaders describe as a “huge step,” Ann Arbor, MI-based precision medicine startup Strata Oncology this week closed a $26 million Series B investment round led ... |
| 13.04.2018 | Sollis Therapeutics Receives up to $50m Investment from Deerfield Management | Sollis Therapeutics, a Columbus, Ohio-based clinical-stage biotechnology company, received an up to $50m investment.
The total equity financing was led by from Deerfield Management.
The company intends to use the funds for the development o... |
| 12.04.2018 | Deerfield Leads Investment of up to $50 Million in Sollis Therapeutics' Innovative Solution for Sciatica Pain | Deerfield Management and Sollis Therapeutics today announced a Deerfield-led investment of up to $50 million in Sollis Therapeutics. The investment will support the development of an innovative non-opioid and non-steroid solution for pain a... |
| 23.03.2018 | Dracen Pharmaceuticals Raises $40M in Series A Funding | Dracen Pharmaceuticals, Inc., a Baltimore, Maryland, United States-based private company developing proprietary anti-cancer drugs discovered at the Johns Hopkins University and the Institute of Organic Chemistry and Biochemistry of the Czec... |
| 22.03.2018 | Deerfield leads oncology startup Dracen Pharma’s $40M series A | Deerfield Management will put up $36 million of Dracen Pharma’s $40 million series A round. The funds will propel the startup’s cancer programs into clinical trials.
The Baltimore-based company came to life in 2017 and is working on cancer ... |
| 20.03.2018 | Monsanto Invests in $25m Series A for Pairwise after Cofounding CRISPR Startup | Pairwise Plants has raised a $25 million Series A round co-led by Monsanto Growth Ventures and healthcare investment firm Deerfield Management.
Pairwise is a gene-editing company that has licensed programmable base editing technology from H... |
| 26.10.2017 | Phoenix Raises $12M in Growth Funding | Phoenix (FKA Phoenix Nuclear Labs), a Monana, Wis.-based developer of nuclear technology, closed on $12M in funding.
The round was led by New York-based Deerfield Management Company with participation from several Wisconsin-based investment... |
| 26.10.2017 | Phoenix Pulls in $12M to Fuel Growth of Neutron Generators | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Things are accelerating at Phoenix.
The Monona, WI-based business, which manufactures particle accelerator-based neutron generators and other machines, has outgrown its curren... |
| 06.02.2017 | Chondrial Therapeutics Raises $22.6 Million | Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $22.6 million in Series A financing led by Deerfield Management and has appoi... |
| 06.02.2017 | Deerfield Leads $22.6M Series A for Chondrial Therapeutics | Chondrial Therapeutics, Inc., an emerging biotechnology company focused on the treatment of rare mitochondrial diseases, announced today that it has secured up to $22.6 million in Series A financing led by Deerfield Management and has appoi... |
| 28.11.2016 | Deerfield close to hitting Fund IV goal after raising $2.4bn | Deerfield Management Company has raised about $2.4bn for its fourth fund, which looks to provide flexible private financ |
| 16.06.2016 | Blade Therapeutics Raises $45M Series B Led by Deerfield Management | Deerfield Management Company today announced its lead investment in the visionary anti-fibrotic company Blade Therapeutics. Blade Therapeutics is developing cutting edge therapies to treat patients with diverse fibrotic diseases for which t... |
| 27.01.2016 | Aprecia Pharmaceuticals Raised $35M in Funding | Aprecia Pharmaceuticals, a Blue Ash, Ohio-based specialty pharmaceutical company using its proprietary 3D printing technology platform to develop and manufacture pharmaceuticals, raised $35m in funding.
The round was led by Deerfield Manage... |
| 17.12.2015 | Hallux Completes $7.1M Series A Financing | Hallux Incorporated, a Laguna Hills, Calif.-based investigational-stage pharmaceutical company focused on developing a new dosage form and route of administration for treating onychomycosis, completed a $7.1m Series A financing.
The round w... |
| 14.12.2015 | Hallux tackles toenail fungus with $7M from Deerfield | “We feel we have the expertise and intellectual property to improve upon what that company had done,” Taylor said, though he won’t indicate which company Hallux acquired the technology from.
One of the most effective therapies for toenail f... |
| 16.09.2015 | Epion Health raises follow-on funding to scale business for new provider customers | Epion Health provides customized intake forms for providers. In addition to asking questions about medical history and the medication patients take, the software-as-a-service tool for mobile devices also provides targeted content. When pati... |
| 10.08.2015 | Genome editing company Editas gets infused with $120M | Investors in the company include Google Ventures, Khosla Ventures and Bill Gates
We like to complain about the world a lot, but this really is such a cool time to be alive. We are coming up with amazing technology at a more rapid pace than ... |
| 10.08.2015 | Daily funding roundup - August 10, 2015 | Editas Medicine Inc secured $120M; Turing Pharmaceuticals bagged $90M; Vainglory raised $26M
Editas Medicine Inc. raised $120 million from investors to support development of a technology that can precisely edit DNA and potentially treat fa... |
| 10.08.2015 | Editas Medicine Raises $20M in Venture Capital Funding | Editas Medicine, a Cambridge, MA-based developer of genome-editing technology, raised $20m in venture capital funding.
Backers included Deerfield Management Company, L.P.‘s Deerfield Healthcare Innovations Fund, L.P., and Deerfield Private ... |
